Inhibikase Therapeutics, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | $3.1M | $-14.8M | $-14.8M |
| FY2022 | $123.4K | $-18.1M | $-18.1M |
| FY2023 | $260.5K | $-20.1M | $-19.0M |
| FY2024 | $0 | $-28.6M | $-27.5M |
| FY2025 | — | $-52.0M | $-48.3M |
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | $3.1M | $-14.8M | $-14.8M |
| FY2022 | $123.4K | $-18.1M | $-18.1M |
| FY2023 | $260.5K | $-20.1M | $-19.0M |
| FY2024 | $0 | $-28.6M | $-27.5M |
| FY2025 | — | $-52.0M | $-48.3M |